APA

Zwaan C. M., Reinhardt D., Zimmerman M., Hasle H., Stary J., Stark B., Dworzak M., Creutzig U. & Kaspers G. J. L. (20100629). Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study. : British journal of haematology.

Chicago

Zwaan Christian M, Reinhardt Dirk, Zimmerman Martin, Hasle Henrik, Stary Jan, Stark Batia, Dworzak Michael, Creutzig Ursula and Kaspers Gertjan J L. 20100629. Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study. : British journal of haematology.

Harvard

Zwaan C. M., Reinhardt D., Zimmerman M., Hasle H., Stary J., Stark B., Dworzak M., Creutzig U. and Kaspers G. J. L. (20100629). Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study. : British journal of haematology.

MLA

Zwaan Christian M, Reinhardt Dirk, Zimmerman Martin, Hasle Henrik, Stary Jan, Stark Batia, Dworzak Michael, Creutzig Ursula and Kaspers Gertjan J L. Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study. : British journal of haematology. 20100629.